| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |